Blocking the G-CSF-R pathway or enhancing negative regulators of G-CSF-R pathway, such as p38 MAPK, ERK, and SOCS3, in lupus-prone mouse models could serve as a proof of concept to validate the involvement of the G-CSF pathway in lupus pathogenesis. Here, CSF3 is linked to systemic lupus erythematosus.